Industry

 Mednow offers on-demand pharmacy services to Curv Health members seeking additional support Curv Health expands the Mednow suite of health services further into diabetes management services TORONTO–(BUSINESS WIRE)–Mednow Inc. (“Mednow”) (TSXV: MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce a strategic partnership with Curv Health, a digital health company that provides low-cost health services … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cardiac Monitoring Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type, Product Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. Cardiovascular Devices Segment to Lead Cardiac Monitoring Devices Market During 2021-2028 Market is expected to grow from US$ 10,523.79 million in 2021 to US$ 16,431.31 … [Read more…]

– Patrick A. Treanor Appointed Effective Immediately – – Dan Soland Resigns in Planned Transition – CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–$KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that Patrick A. Treanor has been appointed and Dan … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Manufacturing Market Research Report by Drug Development Type, Formulation, Therapy Area, Route of Administration Outlook, Prescription, Age Group, Distribution Channels, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical Manufacturing Market size was estimated at USD 454.02 billion in 2021, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Africa Nurse Call System Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering. The country research report on Africa nurse call system market is a customer intelligence and competitive study of the Africa market. Moreover, the report provides deep insights into demand forecasts, market … [Read more…]

– Marks Amneal’s third biosimilar approval in 2022 BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Biologics License Application (“BLA”) for pegfilgrastim-pbbk, a biosimilar referencing Neulasta®. The product will be marketed under the proprietary name FYLNETRA™. FYLNETRA was … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Compound Camphor Ointment Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The global compound camphor ointment market is expected to register a CAGR of 4.1% over the forecast period. Companies Mentioned Caribe Natural LLC Cigna Delon Laboratories Inc. DLC Laboratories Inc. Emu Joy … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “India EMC immunity testing market Forecast to 2028 – COVID-19 Impact and Analysis – by Offering, Industry Vertical and Testing Offering” report has been added to ResearchAndMarkets.com’s offering. India EMC Immunity Testing Market size was valued at US$ 54.01 million in 2021 and is projected to reach US$ 102.37 million by 2028; it … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Reprocessed Medical Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product And End User” report has been added to ResearchAndMarkets.com’s offering. The reprocessed medical devices market is projected to reach US$ 5,653.87 million by 2028 from US$ 2,087.36 million in 2021; it is expected to grow at a CAGR … [Read more…]

ModraDoc006/r at 20-20/200-100mg dosage eliminated neutropenia and significantly decreased neuropathy while maintaining efficacy levels comparable to intravenous (IV) docetaxel Based on strong safety data and encouraging efficacy from the randomized Phase 2b trial, the 20-20/200-100mg dose has been selected for use in planned Phase 3 clinical trial AMSTERDAM–(BUSINESS WIRE)–Modra Pharmaceuticals (“Modra”) today announced the final … [Read more…]